[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Ergomed Plc LSE:ERGO London Ordinary Share GB00BN7ZCY67 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -50.00 -3.42% 1,410.00 1,415.00 1,435.00 1,480.00 1,405.00 1,450.00 56,399 16:35:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 86.4 12.6 20.0 70.5 689

Ergomed Share Discussion Threads

Showing 726 to 750 of 950 messages
Chat Pages: 38  37  36  35  34  33  32  31  30  29  28  27  Older
DateSubjectAuthorDiscuss
25/9/2020
19:37
Yes they were all buys. Every trade is a buy, that's how it works, even for micro caps with market makers. Indeed the larger the volume the less significant they are as it will all just be passing through their hands.
hpcg
25/9/2020
16:23
Some huge trades gone through with no movement. This stock usually moves up or down on very little volume. I would like to think they were buys though.
blueflame
23/9/2020
14:16
My observation is that growth investor do not use either TTM or NTM earnings as a metric. They tend to look at addressable market, revenue growth and potential market cap. For example what to pay if ERGO can get to a billion pound market cap in 3 years? That is a circa 200% gain just from waiting. What if it doesn't do as well and only doubles? This isn't a prediction of the future, just an observation about how the some parts of the market work. It is also the part of the market that has crushed those that won't buy anything with a PE over 10, or a PEG under 0.7.
hpcg
23/9/2020
12:35
Edison valuation in note is based on a 20% premium to their peer group and a PER of well north of 30 for next year. I am not sure what hpcg considers what is rapid growth. But analyst’s projections equate with a growth rate of less than 20% in revenue and EPS YoY for 21 v 20. In my opinion that is above average but far from rapid.
sidam
23/9/2020
12:18
you are probably capable of doing the relevant sums and making your own judgement
phillis
23/9/2020
11:45
Why can't a rapidly growing company have a PE of 40, or 80? Numerous examples around the world.
hpcg
23/9/2020
11:40
Edison are paid by the Company Assume a P?E of 20 and required eps is 42p
phillis
22/9/2020
21:48
Richard Barfield discusses interims here:- proactiveinvestors.co.uk/companies/news/929622/ergomed-confirms-revenues-are-up-over-14-and-cash-position-is--very-strong--929622.html
bermudashorts
22/9/2020
21:24
Edison's note in full with their new 845p target. https://www.edisongroup.com/publication/adj-ebitda-upgrade-despite-industry-challenges/27801
blueflame
22/9/2020
15:44
Reported in Shares magazine this afternoon: Market & Company News: Ergomed profit up 44% as Covid-related trials boost business 22 September 2020, 14:03Source - SMW Pharmaceutical services company Ergomed posted a 44% rise in first-half profit after it won new business, including in Covid-19-related trials, and substantially boosted revenue in North America. The company also said it was planning a capital reduction, in light of its financial progress 'and to increase its ability to pay dividends, to facilitate any prospective buy back of shares and for any other general corporate purposes'. Pre-tax profit for the six months through June increased to £6.0m, up from £4.1m on-year, as revenue climbed 15% to £40.4m, including by 79% in North America. The company did not declare an interim dividend. 'Ergomed has delivered exceptional progress both operationally and financially during the first half of 2020, continuing to demonstrate our ability to drive sustained growth through a clear focus on our service model strategy,' chief executive Miroslav Reljanovic said. 'We responded robustly to the challenges of the Covid-19 pandemic, with strong revenue and profit growth, a growing order book and sales momentum across the business.' 'We expect to see this momentum continue into the second half of the year, driven by further demand for our PV and CRO services.' 'We will continue to invest for organic growth and efficiency with a disciplined approach to strategic acquisition opportunities and are firmly positioned to realise our potential as a leading global provider of specialist services to the pharmaceutical industry.' At 2:03pm: (LON:ERGO) Ergomed Plc share price was +85p at 775p
grabster
22/9/2020
15:09
PVUSA doubled their revenue during the period and looks to be a prime revenue growth producer going forward. RM
rampmeister
22/9/2020
14:12
V overvalued based on expected eps Good business model though All out for the moment
phillis
22/9/2020
14:06
You can now sell at £7.70 . Can hardly get a quote to buy a decent amount.
ihatemms
22/9/2020
14:00
I’m not selling any yet. Barfield’s only got going. With earnings enhancing acquisitions to come, more efficiencies and dividends this is only going 1 way and that’s why the II’s are still piling in even at this lofty price.
ihatemms
22/9/2020
13:54
Edison research note looks OK, but the rating is quite high and the PEG ratio is seriously north of one. Still have some, but with hindsight would have been 10s of thousands less poor if I had not sold any.
sidam
22/9/2020
12:02
just sold another 3000 at 760.5 and up pops my earlier sale of 4000
phillis
22/9/2020
11:53
I agree. But that's what I said 2 months ago at £6 ;-) grabster23 Jul '20 - 08:27 - 682 of 715 Edit 0 0 0 It would be no surprise to see a bit of profit taking at £6 after this recent surge - but if that does create any sort of pullback I shall add, as I am confident of it climbing higher in the coming weeks/months. The current high merely brings it back to the trajectory it was on before the covid effect walloped the stockmarket.
grabster
22/9/2020
11:51
People happy to pay 767p but bound to be profit taking later. RM
rampmeister
22/9/2020
11:48
Ergomed confirms revenues are up over 14% and cash position is 'very strong' ( headline from ProActive Investors report) hTTps://www.proactiveinvestors.co.uk/companies/news/929622/ergomed-confirms-revenues-are-up-over-14-and-cash-position-is--very-strong--929622.html hTTps://www.google.com/search?q=ergomed&rlz=1C1AVFC_enGB864GB864&source=lnms&tbm=nws&;sa=X&ved=2ahUKEwjbwPK7yvzrAhUEURUIHVj8BJUQ_AUoAXoECCQQAw&biw=1536&bih=706 (refresh to update)
grabster
22/9/2020
11:20
Certainly smoking now!
ihatemms
22/9/2020
11:02
just sold 4000 at 732p It isnt showing in Trades yet so there is obviously a large buy order going on in the background
phillis
22/9/2020
10:44
MMs are short of stock That kind of volume would have pushed the stock much much higher No change in bid/ offer spread Why aren’t buyers having to pay 740p
phillis
22/9/2020
10:23
You can now sell at 7.20. The shares are being bought not sold IMHO. Volumes going through the roof - another 200k buy @ 7.30
ihatemms
22/9/2020
09:52
Why do you think that?
blueflame
22/9/2020
09:13
Looks like someone is offloading
phillis
Chat Pages: 38  37  36  35  34  33  32  31  30  29  28  27  Older
ADVFN Advertorial
Your Recent History
LSE
ERGO
Ergomed
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210926 22:53:58